Supplementary Tables from <i>In Vivo</i> Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities

Supplementary Tables from <i>In Vivo</i> Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities

<p>Supplementary file contains all supplementary tables S1-S16 in Excel format in the order in which they appear in the text.</p>

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Elisa ten Hacken (15136187) (author)
Rannpháirtithe:	Tomasz Sewastianik (15127321) (author), Shanye Yin (15136190) (author), Gabriela Brunsting Hoffmann (15136193) (author), Michaela Gruber (15124435) (author), Kendell Clement (14961060) (author), Livius Penter (14960262) (author), Robert A. Redd (15136196) (author), Neil Ruthen (15136199) (author), Sébastien Hergalant (15136202) (author), Alanna Sholokhova (15136205) (author), Geoffrey Fell (15136208) (author), Erin M. Parry (15117803) (author), Julien Broséus (15136211) (author), Romain Guieze (15136214) (author), Fabienne Lucas (14952993) (author), María Hernández-Sánchez (15136217) (author), Kaitlyn Baranowski (15136220) (author), Jackson Southard (14960265) (author), Heather Joyal (15136223) (author), Leah Billington (15136226) (author), Fara Faye D. Regis (15136229) (author), Elizabeth Witten (15136232) (author), Mohamed Uduman (14952996) (author), Binyamin A. Knisbacher (15136235) (author), Shuqiang Li (15136238) (author), Haoxiang Lyu (15136241) (author), Tiziana Vaisitti (15136244) (author), Silvia Deaglio (11386310) (author), Giorgio Inghirami (15136247) (author), Pierre Feugier (15136250) (author), Stephan Stilgenbauer (15136253) (author), Eugen Tausch (15136256) (author), Matthew S. Davids (15136259) (author), Gad Getz (14945542) (author), Kenneth J. Livak (14960271) (author), Ivana Bozic (15136262) (author), Donna S. Neuberg (14953032) (author), Ruben D. Carrasco (15136265) (author), Catherine J. Wu (14944480) (author)
Foilsithe / Cruthaithe:	2025
Ábhair:	Cancer Tumor Biology Methods and Technology Engineering Hematological Cancers Lymphomas Preclinical Models Animal models of cancer Tumor Evolution
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Figure 1 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
de réir: Ernesto Gargiulo (15134961)
Foilsithe / Cruthaithe: (2025)

Figure 2 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
de réir: Ernesto Gargiulo (15134961)
Foilsithe / Cruthaithe: (2025)

Figure 3 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
de réir: Ernesto Gargiulo (15134961)
Foilsithe / Cruthaithe: (2025)

Figure 4 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
de réir: Ernesto Gargiulo (15134961)
Foilsithe / Cruthaithe: (2025)

Figure 5 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
de réir: Ernesto Gargiulo (15134961)
Foilsithe / Cruthaithe: (2025)

Figure 6 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
de réir: Ernesto Gargiulo (15134961)
Foilsithe / Cruthaithe: (2025)

Figure 7 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
de réir: Ernesto Gargiulo (15134961)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S1 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
de réir: Ernesto Gargiulo (15134961)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S2 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
de réir: Ernesto Gargiulo (15134961)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S3 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
de réir: Ernesto Gargiulo (15134961)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S4 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
de réir: Ernesto Gargiulo (15134961)
Foilsithe / Cruthaithe: (2025)

Supplementary Tables from Biallelic <i>Dicer1</i> Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of <i>DICER1</i> Syndrome–Associated Cancer
de réir: Yemin Wang (17315078)
Foilsithe / Cruthaithe: (2025)

Table S5 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer
de réir: Nina Müller (16721126)
Foilsithe / Cruthaithe: (2025)

Table S6 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer
de réir: Nina Müller (16721126)
Foilsithe / Cruthaithe: (2025)

Table S7 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer
de réir: Nina Müller (16721126)
Foilsithe / Cruthaithe: (2025)

Table S8 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer
de réir: Nina Müller (16721126)
Foilsithe / Cruthaithe: (2025)

Figure 1 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
de réir: Nicholas T. Younger (14956251)
Foilsithe / Cruthaithe: (2025)

Figure 2 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
de réir: Nicholas T. Younger (14956251)
Foilsithe / Cruthaithe: (2025)

Figure 3 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
de réir: Nicholas T. Younger (14956251)
Foilsithe / Cruthaithe: (2025)

Figure 4 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
de réir: Nicholas T. Younger (14956251)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
de réir: Ana Vujovic (15207479)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
de réir: Ana Vujovic (15207479)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
de réir: Ana Vujovic (15207479)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
de réir: Ana Vujovic (15207479)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
de réir: Ana Vujovic (15207479)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
de réir: Ana Vujovic (15207479)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
de réir: Ana Vujovic (15207479)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
de réir: Ana Vujovic (15207479)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
de réir: Ana Vujovic (15207479)
Foilsithe / Cruthaithe: (2025)

Strategic Transformation Capability Convergence Analysis.
de réir: Kewei Wang (556371)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S3 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
de réir: Caleb N. Seavey (15056489)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S4 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
de réir: Caleb N. Seavey (15056489)
Foilsithe / Cruthaithe: (2025)

44d_RNAseq_data from A Pro-Regenerative Environment Triggers Premalignant to Malignant Transformation of Senescent Hepatocytes
de réir: Anna Wuestefeld (14963115)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S1 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
de réir: Yufang Bao (15386826)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S2 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
de réir: Yufang Bao (15386826)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S3 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
de réir: Yufang Bao (15386826)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S4 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
de réir: Yufang Bao (15386826)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S5 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
de réir: Yufang Bao (15386826)
Foilsithe / Cruthaithe: (2025)

Table S1 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
de réir: Xun-Xi Lu (14952883)
Foilsithe / Cruthaithe: (2025)

Table S2 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
de réir: Xun-Xi Lu (14952883)
Foilsithe / Cruthaithe: (2025)

Cannot write session to /tmp/vufind_sessions/sess_dpaddg4skep0angjgonmlibmvh